First ventilators from new UK production run due this weekend

© Reuters. Britain’s Chancellor of the Duchy of Lancaster Michael Gove speaks at a digital news conference on the coronavirus disease (COVID-19) outbreak, at 10 Downing Street in London


LONDON (Reuters) – The first medical ventilators which Britain has recently ordered from businesses will be ready this weekend and available to the National Health Service next week, as the country seeks to boost capacity in the coronavirus outbreak.

Britain has ordered 10,000 of the breathing machines from a consortium including Ford, Airbus and McLaren with other companies such as vacuum cleaner-maker Dyson also producing their own equivalents.

“This weekend the first thousands of new ventilator devices will roll off the production line and be delivered to the NHS next week,” cabinet office minister Michael Gove told reporters.

“From there they will be rapidly distributed to the front line.”

The first delivery would be of the consortium’s Penlon model, which has been rapidly adapted from existing devices and given regulatory approval. Hundreds more could follow, the government said in a separate statement.

The Daily Mail reported that the first batch would be 30 units. The Cabinet Office, which is co-ordinating procurement, said it could not immediately confirm the size of the first delivery.

On Tuesday, another company, Science Group, said it is negotiating a contract with the government for the production of 10,000 ventilators subject to regulatory approval.

“A working prototype of the Sagentia Ventilator has been produced and 20 trial units are currently in the process of being manufactured,” it said in a statement.

READ  We risk a return to 1970s stagflation
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.



Please enter your comment!
Please enter your name here